Drug Topics

SEPTEMBER 28, 2023

A new study from Dartmouth College found that patients maintained healthier blood sugar levels from April to September.

503

503

PharmaVoice

SEPTEMBER 28, 2023

A recent report showed how pharma’s bonuses pale in comparison to other industries, but several execs still rake in hefty packages.

Packaging 238

Packaging 238

Drug Topics

SEPTEMBER 28, 2023

A new study found that the most common symptoms that cannabis was used to treat were chronic pain, anxiety, sleep problems, and stress.

469

469

PharmaVoice

SEPTEMBER 28, 2023

As Medicare negotiations heat up, it’s more important than ever for pharma companies to communicate their value. Here’s how.

Communication 182

Communication 182

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

SEPTEMBER 28, 2023

Beyond female gender, comorbidities independently associated with C diff infection in patients diagnosed with COVID-19 included peptic ulcer disease, renal failure, weight loss, diabetes mellitus with complications, and congestive heart failure.

247

247

STAT

SEPTEMBER 28, 2023

New data released Thursday by the National Science Foundation show the exodus of young life scientists from the Ivory Tower to industry has reached the highest level in nearly three decades, deepening concerns about the future of academic science in the U.S. Among newly minted life science Ph.D.s in 2022 who had firm next steps, roughly 53% planned to pursue postdoctoral research, a temporary period of additional training that is virtually a requirement for those hoping to land a faculty job.

145

145

STAT

SEPTEMBER 28, 2023

Vaccination rates against flu and Covid-19 have declined since earlier in the pandemic and a new survey suggests significant portions of the U.S. population intend to forgo these vaccines this fall. The survey, conducted by the National Foundation for Infectious Diseases, suggests only about one in five Americans worry that they or someone in their family will contract influenza, Covid, or RSV — respiratory syncytial virus.

Vaccines 145

Vaccines 145

Pharmacy Times

SEPTEMBER 28, 2023

In this final episode, we spoke with Claudia Fox, MD, MPH, FAAP, an associate professor of pediatrics at the University of Minnesota Medical School in Minneapolis.

Medical Schools 145

Medical Schools 145

STAT

SEPTEMBER 28, 2023

SAN FRANCISCO — It was during some of the darkest days of the pandemic — November 2020 — when Melissa Lawson, 36, was helicoptered from an emergency room in Santa Rosa, Calif., to a hospital here, her blood so thick with white blood cells doctors thought she might not survive the night. She did, after undergoing a procedure to clear her blood.

Hospitals 141

Hospitals 141

Pharmacy Times

SEPTEMBER 28, 2023

At a 6-month follow-up, supplemental creatine intervention significantly improved scores for fatigue symptoms and tissue bioenergetics related to COVID-19 infection.

145

145

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

SEPTEMBER 28, 2023

This article is adapted from STAT’s exclusive analysis in the STAT Report: “Climate rankings: How top drug companies measure up in combating climate change.” D rug companies are major contributors to climate change, both through direct greenhouse gas emissions and especially through their supply chains. But the pharmaceutical industry has lagged behind others when it comes to understanding and cutting down on its climate impact.

136

136

Pharmacy Times

SEPTEMBER 28, 2023

Gepirone hydrochloride ER (Exxua; Fabre-Kramer Pharmaceuticals Inc) is in a new class of antidepressants, making it the first and only approved antidepressant that selectively targets serotonin 1A receptors.

FDA 145

FDA 145

STAT

SEPTEMBER 28, 2023

Have you ever needed to read a research paper, only to find it was locked behind a paywall? Your next step was likely to search on Sci-Hub , an illegal repository created by Kazakh graduate student Alexandra Elbakyan, that provides free access to millions of research papers. While Sci-Hub is controversial, its widespread use points to a crucial question: Shouldn’t taxpayer-funded research be freely and immediately accessible to the public?

136

136

Pharmacy Times

SEPTEMBER 28, 2023

The National Community Pharmacists Association said the action was sent into motion by wrongful penalties for Medicare Part D prescriptions, called pharmacy direct and indirect remuneration fees.

Independent Pharmacies 145

Independent Pharmacies 145

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

SEPTEMBER 28, 2023

The severing of ties between two of Boston’s biggest health care giants has placed one of the nation’s largest health care systems in the position of figuring out how, exactly, to fill a new hole in its oncology services, at a time when cancer care is changing rapidly. Earlier this month, Dana-Farber Cancer Institute surprised the medical community and even its partner, Brigham and Women’s Hospital, when it announced that it would end their nearly 30-year collaboration.

Hospitals 129

Hospitals 129

Pharmacy Times

SEPTEMBER 28, 2023

Teprotumumab (Tepezza) is a promising treatment for thyroid eye disease , although its precise mechanism of action remains incompletely characterized.

145

145

Pharmaceutical Technology

SEPTEMBER 28, 2023

The company’s algorithms put proteins through millions of years of simulated evolution to identify potential functional candidates.

126

126

Pharmacy Times

SEPTEMBER 28, 2023

Abrocitinib can reduce allergic responses in patients with a peanut allergy by decreasing cytokine activity and maintaining regulatory T cell activation.

132

132

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

SEPTEMBER 28, 2023

Telehealth continues to enjoy elevated popularity thanks to the COVID-19 pandemic, but significant generational gaps persist in satisfaction, according to a

125

125

Pharmacy Times

SEPTEMBER 28, 2023

Pharmacists are experts at juggling shortages of all kinds, however, and L’Altrelli said they are crucial team members regarding opioid access challenges.

123

123

STAT

SEPTEMBER 28, 2023

Ophthalmologists who accepted payments from drug companies were less likely to prescribe a cheaper medicine to treat an eye disease that causes blindness in older people, rather than a pair of more expensive alternatives, according to a new study. This led Medicare to spend an additional $643 million during a recent six-year period. Specifically, physicians who received money prescribed Avastin, an older cancer medicine, 28% of the time for combating age-related macular degeneration.

Insurance 123

Insurance 123

Fierce Healthcare

SEPTEMBER 28, 2023

Despite large financial investments, digital front door solutions still fall short, leading to patient leakage and additional work for already overburdened staff. | From appointment scheduling to real-time analytics – discover how conversational AI is setting a new standard for patient access.

121

121

STAT

SEPTEMBER 28, 2023

For all their potential to drive changes in health, wearables have struggled to gain a foothold in medicine. The dramatic changes during pregnancy are a fertile ground to test their potential, though — and new research shows how applying machine learning methods to streams of data from wearable devices could be used to understand the mystery of premature birth.

122

122

Fierce Healthcare

SEPTEMBER 28, 2023

At-home diagnostics startup Viome Life Sciences has launched a new test to help detect oral and throat cancers. | The test relies on Viome’s proprietary RNA sequencing technology and AI to measure gene expression of the oral microbiome and human cells in each patient’s saliva, which are used to identify early biomarkers associated with oral and throat cancers.

120

120

STAT

SEPTEMBER 28, 2023

WASHINGTON — Republicans and Democrats alike want to stop drug shortages from happening. The vexing question is how. The White House and a whole host of government agencies oversee programs aimed at mitigating drug shortages, including the Food and Drug Administration, the Administration for Strategic Preparedness and Response, the White House Office of Science and Technology Policy, the Department of Defense, and the Department of Commerce.

Chemotherapy 121

Chemotherapy Hospitals 121

pharmaphorum

SEPTEMBER 28, 2023

Understanding and addressing care disparities in rare cancers Mike.

119

119

Fierce Pharma

SEPTEMBER 28, 2023

Fabre-Kramer Pharmaceuticals' major depressive disorder (MDD) drug gepirone has been rejected by the FDA not once, not twice, but three times since the turn of the millennium. | Fabre-Kramer's Exxua suffered three prior FDA rejections before scoring an FDA approval for major depressive disorder last week. Its label doesn't include sexual dysfunction as an adverse reaction, which is rare among antidepressants.

Adverse Reactions 116

Adverse Reactions FDA Labelling 116

Outsourcing Pharma

SEPTEMBER 28, 2023

A study to evaluate the effect of seladelparm, a small molecule treatment by CymaBay Therapeutics, Inc. on patients with cirrhosis was announced this month (September 21).

115

115

STAT

SEPTEMBER 28, 2023

The Danish pharmaceutical company Novo Nordisk has shepherded all kinds of medical innovation in the 110 years since it was founded. But the booming success of its diabetes and obesity drug is unlike anything executives have seen before. The company’s mid-year operating profit jumped from 37.5 billion danish kroner in 2022 to 48.9 billion danish kroner this year — “probably the strongest growth in the history of the company,” Chief Financial Officer Karsten Munk Knuds

Pharmaceutical Companies 113

Pharmaceutical Companies Pharmaceutical Companies 113

Fierce Healthcare

SEPTEMBER 28, 2023

Following a Senate Finance Committee markup hearing in July, where members voted 26-1 in favor of the Modernizing and Ensuring PBM Accountability (MEPA) Act, Senators Ron Wyden, D-Oregon, and Mike | Legislation targeting pharmacy benefit managers with bipartisan support has been introduced in the Senate.

111

111

Drug Store News

SEPTEMBER 28, 2023

The Tazo Café Collective, launching with support from Issa Rae, is calling on local and independent cafes to help create new tea and latte drinks.

111

111

pharmaphorum

SEPTEMBER 28, 2023

CureVac claims advantage in BioNTech patent dispute Phil.

111

111

Fierce Healthcare

SEPTEMBER 28, 2023

Komodo Health, a health data company, has announced a new all-in-one offering for healthcare and life sciences companies to generate analytical insights. | MapLab includes robust data science tooling, customizable analytics dashboards and a generative AI analytic assistant.

111

111